ACTU vs XPO · $49.0M cap vs P/E 69, rev $2.35B
Actuate Therapeutics, Inc. Common stock (ACTU) versus XPO Logistics Inc (XPO) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
XPO Logistics Inc (XPO) is a trucking company listed on NYSE.
ACTU does not have a complete income-statement cache yet.
Latest reported XPO revenue for 2026-06-30 was $2.35B. Net income was $162.0M. Revenue was up 12.4% from 2026-03-31 to 2026-06-30. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
ACTU currently screens at market cap $49.0M. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
Not investment advice. Open the ACTU and XPO stock pages for the full models.
Not investment advice.